[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.120.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
October 27, 2004

Enoxaparin vs Unfractionated Heparin in Acute Coronary Syndrome—Reply

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2004;292(16):1952-1953. doi:10.1001/jama.292.16.1953-a

In Reply: In response to Dr Pedrini and colleagues, we did not design our study to evaluate the important question of the duration of antithrombin therapy. Our protocol suggested a minimum duration of treatment with unfractionated or low-molecular-weight heparin of 48 hours, but treatment duration could be shortened for those undergoing early percutaneous intervention, with heparin discontinuation permitted 12 hours after intervention. Maximal duration for study-provided medications was limited to 120 hours by protocol. Although not based on data from randomized controlled trials, this strategy is consistent with American College of Cardiology/American Heart Association guideline recommendations.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×